FY 2016 Announcement of Anticipated Availability of Funds for Family Planning Services Grants ...

40 Pages·2016·0.33 MB·English

DEPARTMENT OF HEALTH AND HUMAN SERVICES
AGENCY: Office of the Assistant Secretary for Health, Office of Population Affairs
FUNDING OPPORTUNITY TITLE: FY 2016 Announcement of Availability of
Funds for a Project to Develop Patient Reported Outcome Performance Measures for
Contraceptive Services
ACTION: Notice
ANNOUNCEMENT TYPE: Initial Competitive Cooperative Agreement
FUNDING OPPORTUNITY NUMBER: PA-FPR-16-001
CFDA NUMBER: 93.974
CFDA PROGRAM: Family Planning Service Delivery Improvement Grants
DATES: Non-binding letters of intent are due February 29, 2016

Your application is due April 15, 2016 by 5 p.m. Eastern Time. To receive consideration, your
application must be received electronically via Grants.gov by the HHS Office of the Assistant
Secretary for Health (HHS/OASH), Office of Grants Management (OGM) no later than this due
date and time. If your application does not meet the specified deadline it will be returned to you
unread. You must submit electronically via Grants.gov unless you obtain a written exemption
from this requirement 2 business days in advance of the deadline from the Director, HHS/OASH
Office of Grants Management. To obtain an exemption, you must request one via email from the
HHS/OASH Office of Grants Management, and provide details as to why you are
technologically unable to submit electronically through Grants.gov portal. Your request should
be submitted at least 4 business days prior to the application deadline to ensure your request can
1
be considered prior to 2 business days in advance of the deadline. If you request an exemption,
include the following in your e-mail request: the HHS/OASH announcement number; your
organization's DUNS number; your organization’s name, address and telephone number; the
name and telephone number of your Authorizing Official; the Grants.gov Tracking Number
(GRANTXXXX) assigned to your submission; and a copy of the "Rejected with Errors"
notification from Grants.gov. Send the request with supporting documentation to
[email protected]. Note: failure to have an active System for Account Management (SAM)
registration will not be grounds for receiving an exemption to the electronic submission
requirement.
The HHS/OASH Office of Grants Management will only accept applications via
alternate methods (hardcopy paper via US mail or other provider or PDF via email) from
applicants obtaining prior written approval. The application must still be submitted by the
deadline. Only applications submitted through the Grants.gov portal or alternate format
(hardcopy paper via US mail or other service or PDF via email) with an approved written
exemption will be accepted. See Section D.7. (“Other Submission Requirements”) for
information on application submission mechanisms.
To ensure adequate time to successfully submit your application, HHS/OASH
recommends that you register as early as possible in Grants.gov since the registration process
can take up to one month. For information on registering for Grants.gov, refer to
http://www.grants.gov or contact the Grants.gov Contact Center 24 hours a day, 7 days a week
(excluding Federal holidays) at 1-800-518-4726 or [email protected].
2
Your organization is strongly encouraged to register multiple authorized
organization representatives in Grants.gov to ensure someone is available to submit your
application.

Technical Assistance: There will be a technical assistance webinar to briefly review the
application process as well as the content of the funding opportunity announcement.
Representatives from the Office of Population Affairs (OPA) will be presenting information
relevant to the FOA during the webinar. The webinar will be held only once, but will be posted
on the OPA website following the event. The date for this webinar will be located on the OPA
website at (http://www.hhs.gov/opa/).

EXECUTIVE SUMMARY: The Office of Population Affairs (OPA) within the Office of the
Assistant Secretary for Health (OASH) announces the availability of funds for Fiscal Year (FY)
2016 a cooperative agreement under Section 1004 of the Public Health Service Act to develop a
patient-reported outcome performance measure (PRO-PM) for contraceptive services. Public
and private nonprofit entities may apply.

The long-term, overarching goal of this effort is to improve reproductive health outcomes for
men, women and adolescents by reducing unplanned pregnancies, improving birth spacing, and
improving maternal and infant health. The use of clinical performance measures in the context
of broader quality improvement processes has been shown to improve the quality of care,[1]
which in turn can improve health outcomes.[2] The Institute of Healthcare Improvement’s
3
Triple Aim has highlighted the importance of using quality improvement to monitor and drive
improvements in health outcomes, client experience and cost savings.[3]

This funding opportunity focuses on filling a critical gap in performance measures for family
planning services, i.e., the need for validated measures of client experience in contraceptive
services. OPA intends that the measure will be developed in a manner such that the measure
may subsequently be submitted to the National Quality Forum (NQF) for endorsement, either by
the awardee or by the Office of Population Affairs.

A. PROGRAM DESCRIPTION:
The primary objective of this FOA is to develop a patient-reported outcome performance
measure (PRO-PM) for contraceptive services, in a manner in which it may be submitted to the
National Quality Forum (NQF) for endorsement. The use of clinical performance measures in
the context of broader quality improvement processes has been shown to improve the quality of
care.[1] The Triple Aim has highlighted the importance of using quality improvement to
monitor and drive improvements in health outcomes, client experience and cost savings.[3] This
effort focuses on filling a critical gap in performance measures, i.e., the need for validated
measures of client experience with contraceptive services.

Given the sensitive nature of contraceptive services and the potential for coercive practices,[4-7]
it is particularly important to ensure that they are provided in a client-centered manner. OPA
and the U.S. Centers for Disease Control and Prevention’s CDC’s clinical recommendations
entitled Providing Quality Family Planning Services, 2014 (QFP) emphasize the need for and
4
describe how to provide client-centered contraceptive services, and will be used to inform the
development of the PRO-PM.[8] As such, “client-centered” contraceptive services are defined
as follows:

Client-centered is defined as providing care that treats each person as a unique
individual with respect, empathy and understanding, providing accurate, easy-
to-understand information based on the client’s needs and goals, and reflecting
the client’s preferences for decision making.

PRO performance measures capture the client’s report of how care is provided and are an
essential aspect of monitoring health care quality.[3, 9] OPA anticipates that the measure will
focus on the client’s actual experience of care, rather than on satisfaction with the services.[10]
The Consumer Assessment of Healthcare Providers and Systems (CAHPS) program is an
example of a standardized questionnaire assessing consumers’ experience with health care
(www.cahps.ahrq/gov). Reports about experience with care are often regarded as more specific,
actionable, understandable and objective than general satisfaction ratings alone.

The measure will be designed for use in any setting where contraceptive services are provided,
including the Title X and other publicly funded primary care and family planning programs (e.g.,
by Medicaid providers or HRSA-supported community health centers).

5
The measure should be developed in accordance with National Quality Forum (NQF) guidance
on this topic to ensure it is as rigorously validated as possible.[11] The NQF guidance includes
the following steps:

• Define the patient reported outcome (PRO), e.g., obtain input from key stakeholders (such as
patients, providers, and policymakers) and identify meaningful outcomes.
• Identify an appropriate patient reported outcome measure (PROM) for measuring the outcome in the
target population of interest, which is reliable (internal consistency and reproducibility) and valid. If
no existing PROM seems to be suitable, then a new PROM should be tested in the target population
and in the intended setting to identify feasibility issues related to administration, data capture and
workflow, provide feedback for self-management, and facilitate shared decision making.
• Specify and test a patient reported outcome performance measure (PRO-PM).

It is OPA’s intention that the measure be submitted to NQF for endorsement after the
developmental steps listed above are completed. NQF endorsement will greatly increase the
chances that the measure will be used by public programs and private health plans. The entity
that has been funded to develop the measure may submit the measure to NQF if it chooses to do
so, and is willing to serve as the measure’s steward in accordance with NQF requirements.
However, OPA financial support for fulfilling the steward’s responsibilities is not part of this
FOA and cannot be guaranteed. If the awardee decides against submitting the measure to NQF,
then OPA will have the opportunity to submit the measure to NQF and serve as the measure’s
steward.

6
The administrative and funding instrument used for this program will be a cooperative
agreement, in which substantial OPA involvement should be expected to be above and beyond
the normal stewardship role in awards. Under the cooperative agreement, OPA intends to
support the awardee’s activities by working jointly in a partnership role; it is not to assume prime
responsibility or a dominant role in the activities. As such, OPA will maintain substantial
involvement with, and monitoring of, the recipient as the project progresses. Regular
communication with the assigned OPA project officer via email and conference calls scheduled
every other month will be expected. For this cooperative agreement, the recipient will have lead
responsibilities in all aspects of the study, including the recruitment plan and conduct of the
study. Study instruments and draft publications will also require review by OPA. To help ensure
responsiveness to OPA program priorities and direction, OPA will collaborate with the recipient
as appropriate, and provide consultation, assistance, and support in planning and implementing
all aspects of the proposed plan.

AUTHORITY: The authority for cooperative agreements for Title X research is set out at
Section 1004 (42 U.S.C. §300a-2) of the Public Health Service Act. The statute states that “the
Secretary may (1) conduct, and (2) make grants to public or nonprofit private entities and enter
into contracts with public or private entities and individuals for projects for, research in the
biomedical, contraceptive development, behavioral, and program implementation fields related
to family planning and population.” Applicants should consult the Title X statute and
regulations that are available on the OPA website, http://hhs.gov/opa, as well as other
information included in this announcement, and in the application kit in developing their
applications.
7
B. FEDERAL AWARD INFORMATION
The Office of Population Affairs intends to make available approximately $400,000 for a
competing cooperative agreement. We will fund grants in annual increments (budget periods)
and generally for a project period of up to 3 years, although we may approve shorter project
periods. Funding for all approved budget periods beyond the first year of the grant is generally
level with the initial award amount and is contingent upon the availability of funds, satisfactory
progress of the project, and adequate stewardship of Federal funds.
Award Information
Estimated Funds Available for Competition: $400,000
Anticipated Number of Awards: One
Range of Awards: $300,000-400,000 per budget period
Anticipated Start Date: 07/01/2016
Period of Performance: Not to exceed 3 years
Budget Period Length: 12 months
Type of Award: Cooperative Agreement. Agency substantial involvement is outlined in
the Program Description in Section A.
Type of Application Accepted: Electronic via Grants.gov ONLY unless an exemption is
granted
C. ELIGIBILITY INFORMATION
1. Eligible Applicants.
2. Any public or private nonprofit entity located in any one of the 50 United States, the District
of Columbia, Commonwealth of Puerto Rico, U.S. Virgin Islands, Commonwealth of the
8
Northern Mariana Islands, American Samoa, Guam, Republic of Palau, Federated States of
Micronesia, and the Republic of the Marshall Islands is eligible to apply for a grant under
this announcement. Faith-based organizations and American Indian/Alaskan Native/Native
American (AI/AN/NA) organizations are eligible to apply for this Title X family planning
research cooperative agreement. Private nonprofit entities must provide proof of nonprofit
status. See Section IV. 2 for information regarding acceptable proof of nonprofit status. Cost
Sharing or Matching
Cost sharing or matching funds are not required for this program.
3. Other Eligibility Information
Application Screening Criteria
If your application is appropriately submitted, it will be screened to assure a level playing
field for all applicants. If duplicate applications from the same organization for the same project
are successfully submitted, only the last application received by the deadline will be reviewed. If
your application fails to meet the screening criteria described below it will not be reviewed and
will receive no further consideration.
1. Your application must be submitted electronically via www.grants.gov (unless an exemption
was granted 2 business days prior to the deadline) by 5 pm ET on April 15, 2016.
2. Your Project Narrative section of the application must be double-spaced, on the equivalent of
8 ½ ” x 11” inch page size, with 1” margins on all sides (top, bottom, left and right) and font
size not less than 12 points.
3. Your Project Narrative must not exceed 40 pages. NOTE: The following items do not count
toward the page limit: all required forms, including SF-424, SF-424A, SF-424B, SF-LLL,
Project Abstract Summary, and Budget Narrative (including budget tables).
9
4. Your total application, including the Project Narrative plus Appendices, must not exceed 100
pages. NOTE: items noted in #3 above do not count toward total page limit.
5. Your proposed budget does not exceed the maximum indicated in Range of Awards.
6. Your application meets the Application Responsiveness Criteria outlined above.

D. APPLICATION AND SUBMISSION INFORMATION
1. Address to Request Application Package
You may obtain an application package electronically by accessing Grants.gov at
http://www.grants.gov/. You can find it by searching on the CFDA number shown on page 1 of
this funding opportunity announcement. If you have problems accessing the application or
difficulty downloading, contact:
Office of Grants Management
Phone: [phone]
Email: [email protected]
2. Content and Form of Application Submission
i. Letter of Intent – Requested.
If you plan to apply for this funding opportunity, you should submit a letter of intent as early as
possible, but no later than the deadline indicated in DATES on page 1 of this announcement].
Although you are not required to submit a letter of intent, the information that it contains allows
HHS/OASH to estimate the potential review workload and plan the review. A letter of intent is
not binding, and does not enter into the review of a subsequent application. Your letter of intent
should include a descriptive title of your proposed project, the name, address and telephone
10